Bio-Rad Laboratories (NYSE:BIO.B) Sees Strong Trading Volume – Should You Buy?

Bio-Rad Laboratories, Inc. (NYSE:BIO.B) saw strong trading volume on Friday . 380 shares traded hands during trading, an increase of 27% from the previous session’s volume of 300 shares.The stock last traded at $255.54 and had previously closed at $258.46.

Bio-Rad Laboratories Stock Performance

The company has a market cap of $6.90 billion, a PE ratio of 42.10 and a beta of 0.96. The company has a debt-to-equity ratio of 0.12, a quick ratio of 2.37 and a current ratio of 3.21. The stock’s 50-day simple moving average is $276.18 and its 200 day simple moving average is $294.91.

Bio-Rad Laboratories (NYSE:BIO.B) last announced its quarterly earnings data on Thursday, April 30th. The company reported $1.89 EPS for the quarter. Bio-Rad Laboratories had a net margin of 6.52% and a return on equity of 3.56%.

Bio-Rad Laboratories Company Profile

Bio-Rad Laboratories, Inc is a global provider of innovative products and systems that serve the life science research and clinical diagnostics markets. The company operates through two primary segments: Life Science, which delivers instruments, consumables and software for research applications, and Clinical Diagnostics, which offers quality control materials and reagent systems for blood typing, immunology and molecular testing. Bio-Rad’s product portfolio supports a wide range of applications, including protein analysis, gene expression, cell biology and digital PCR.

In the Life Science segment, Bio-Rad develops and markets technologies such as electrophoresis and imaging systems, chromatography instruments, laboratory consumables and software platforms that streamline experimental workflows.